These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 12148857

  • 1. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES.
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [Abstract] [Full Text] [Related]

  • 2. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, Jen J, Sidransky D.
    Oncogene; 1999 Jun 10; 18(23):3541-5. PubMed ID: 10376532
    [Abstract] [Full Text] [Related]

  • 3. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP.
    Cancer; 1997 Jan 15; 79(2):380-9. PubMed ID: 9010112
    [Abstract] [Full Text] [Related]

  • 4. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
    Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, Ro JY, El-Naggar A, Hong WK, Hittelman WN.
    Oncogene; 1998 Nov 05; 17(18):2313-22. PubMed ID: 9811462
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
    Lai S, El-Naggar AK.
    Lab Invest; 1999 Mar 05; 79(3):255-60. PubMed ID: 10092061
    [Abstract] [Full Text] [Related]

  • 6. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas.
    Uzawa N, Sonoda I, Myo K, Takahashi K, Miyamoto R, Amagasa T.
    Cancer; 2007 Nov 15; 110(10):2230-9. PubMed ID: 17893905
    [Abstract] [Full Text] [Related]

  • 7. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J, Bockmühl U, Petersen I, Yang K, Carey TE, Kurnit DM.
    Clin Cancer Res; 2003 May 15; 9(5):1750-5. PubMed ID: 12738730
    [Abstract] [Full Text] [Related]

  • 8. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.
    Park HW, Song SY, Lee TJ, Jeong D, Lee TY.
    Oncol Rep; 2007 Jul 15; 18(1):267-72. PubMed ID: 17549378
    [Abstract] [Full Text] [Related]

  • 9. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
    Takeuchi H, Ozawa S, Ando N, Shih CH, Koyanagi K, Ueda M, Kitajima M.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2229-36. PubMed ID: 9815619
    [Abstract] [Full Text] [Related]

  • 10. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
    Akervall J, Borg A, Dictor M, Jin C, Jin Y, Tanner M, Isola J, Mertens F, Wennerberg J.
    Int J Oncol; 2002 Jan 15; 20(1):45-52. PubMed ID: 11743641
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A.
    Cancer Res; 1995 Mar 01; 55(5):975-8. PubMed ID: 7867006
    [Abstract] [Full Text] [Related]

  • 12. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
    Liu SC, Zhang SY, Babb JS, Ridge JA, Klein-Szanto AJ.
    Cancer Epidemiol Biomarkers Prev; 2001 May 01; 10(5):455-9. PubMed ID: 11352854
    [Abstract] [Full Text] [Related]

  • 13. Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development.
    Papadimitrakopoulou VA, Izzo J, Mao L, Keck J, Hamilton D, Shin DM, El-Naggar A, den Hollander P, Liu D, Hittelman WN, Hong WK.
    Clin Cancer Res; 2001 Oct 01; 7(10):3127-34. PubMed ID: 11595705
    [Abstract] [Full Text] [Related]

  • 14. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S, Ahmed MI, Said H, Zaghlool A, El-Ahmady O.
    IUBMB Life; 2004 Sep 01; 56(9):557-64. PubMed ID: 15590562
    [Abstract] [Full Text] [Related]

  • 15. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M.
    Br J Cancer; 1999 Apr 01; 80(1-2):79-86. PubMed ID: 10389982
    [Abstract] [Full Text] [Related]

  • 16. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization.
    Wang MB, Alavi S, Engstrom M, Lee J, Namazie A, Moatamed F, Srivatsan ES.
    Anticancer Res; 1999 Apr 01; 19(2A):925-31. PubMed ID: 10368635
    [Abstract] [Full Text] [Related]

  • 17. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L, Stephenson KK, Ling W, Zuo C, Mukunyadzi P, Suen JY, Hanna E, Fan CY.
    Mod Pathol; 2003 Sep 01; 16(9):944-50. PubMed ID: 13679459
    [Abstract] [Full Text] [Related]

  • 18. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM.
    J Pathol; 2009 Mar 01; 217(4):516-23. PubMed ID: 18991334
    [Abstract] [Full Text] [Related]

  • 19. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB.
    Cancer Res; 2002 Jun 15; 62(12):3351-5. PubMed ID: 12067972
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.